Replies to post #3303 on Galectin Therapeutics Inc. (GALT)

[sokol]

As I remember, Richard Uihlein’s $10 million loan or line of credit projected funds for the company into 2019.

In the meantime, I am interested in the late breaker oral presentation that will be made April 14, at the International Liver Congress in Europe.